ホスホイノシチド3-キナーゼ阻害剤のグローバル市場インサイト・予測（～2028年）

• 英文タイトル：Global Phosphoinositide 3-Kinase Inhibitor Market Insights, Forecast to 2028

• レポートコード：QY2207E10465 • 出版社/出版日：QYResearch / 2022年7月 • レポート形態：英文、PDF、95ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥735,000 (USD4,900)	▷ お問い合わせ
Multi User	￥1,102,500 (USD7,350)	▷ お問い合わせ
Enterprise License	￥1,470,000 (USD9,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

新型コロナウイルス感染症のパンデミックにより、世界のホスホイノシチド3-キナーゼ阻害剤の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にホスホイノシチド3-キナーゼ阻害剤の世界市場のxxx％を占める「Pan-PI3K阻害剤」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「CLL/SLL-慢性リンパ性白血病/小リンパ球性リンパ腫」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。 中国のホスホイノシチド3-キナーゼ阻害剤の市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパのホスホイノシチド3-キナーゼ阻害剤市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパのホスホイノシチド3-キナーゼ阻害剤市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。 ホスホイノシチド3-キナーゼ阻害剤のグローバル主要メーカーには、Bayer AG、Gilead Sciences Inc.、Novartis AG、TG Therapeutics Inc.、Secura Bio, Inc.などがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 ホスホイノシチド3-キナーゼ阻害剤市場は、種類と用途によって区分されます。世界のホスホイノシチド3-キナーゼ阻害剤市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。 【種類別セグメント】 Pan-PI3K阻害剤、デュアルPI3K/mTOR阻害剤、その他 【用途別セグメント】 CLL/SLL-慢性リンパ性白血病/小リンパ球性リンパ腫、FL-濾胞性リンパ腫、その他 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - ホスホイノシチド3-キナーゼ阻害剤製品概要 - 種類別市場（Pan-PI3K阻害剤、デュアルPI3K/mTOR阻害剤、その他） - 用途別市場（CLL/SLL-慢性リンパ性白血病/小リンパ球性リンパ腫、FL-濾胞性リンパ腫、その他） - 調査の目的 ・エグゼクティブサマリー - 世界のホスホイノシチド3-キナーゼ阻害剤販売量予測2017-2028 - 世界のホスホイノシチド3-キナーゼ阻害剤売上予測2017-2028 - ホスホイノシチド3-キナーゼ阻害剤の地域別販売量 - ホスホイノシチド3-キナーゼ阻害剤の地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別ホスホイノシチド3-キナーゼ阻害剤販売量 - 主要メーカー別ホスホイノシチド3-キナーゼ阻害剤売上 - 主要メーカー別ホスホイノシチド3-キナーゼ阻害剤価格 - 競争状況の分析 - 企業M&A動向 ・種類別市場規模（Pan-PI3K阻害剤、デュアルPI3K/mTOR阻害剤、その他） - ホスホイノシチド3-キナーゼ阻害剤の種類別販売量 - ホスホイノシチド3-キナーゼ阻害剤の種類別売上 - ホスホイノシチド3-キナーゼ阻害剤の種類別価格 ・用途別市場規模（CLL/SLL-慢性リンパ性白血病/小リンパ球性リンパ腫、FL-濾胞性リンパ腫、その他） - ホスホイノシチド3-キナーゼ阻害剤の用途別販売量 - ホスホイノシチド3-キナーゼ阻害剤の用途別売上 - ホスホイノシチド3-キナーゼ阻害剤の用途別価格 ・北米市場 - 北米のホスホイノシチド3-キナーゼ阻害剤市場規模（種類別、用途別） - 主要国別のホスホイノシチド3-キナーゼ阻害剤市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパのホスホイノシチド3-キナーゼ阻害剤市場規模（種類別、用途別） - 主要国別のホスホイノシチド3-キナーゼ阻害剤市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋のホスホイノシチド3-キナーゼ阻害剤市場規模（種類別、用途別） - 主要国別のホスホイノシチド3-キナーゼ阻害剤市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米のホスホイノシチド3-キナーゼ阻害剤市場規模（種類別、用途別） - 主要国別のホスホイノシチド3-キナーゼ阻害剤市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカのホスホイノシチド3-キナーゼ阻害剤市場規模（種類別、用途別） - 主要国別のホスホイノシチド3-キナーゼ阻害剤市場規模（トルコ、サウジアラビア） ・企業情報 Bayer AG、Gilead Sciences Inc.、Novartis AG、TG Therapeutics Inc.、Secura Bio, Inc. ・産業チェーン及び販売チャネル分析 - ホスホイノシチド3-キナーゼ阻害剤の産業チェーン分析 - ホスホイノシチド3-キナーゼ阻害剤の原材料 - ホスホイノシチド3-キナーゼ阻害剤の生産プロセス - ホスホイノシチド3-キナーゼ阻害剤の販売及びマーケティング - ホスホイノシチド3-キナーゼ阻害剤の主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - ホスホイノシチド3-キナーゼ阻害剤の産業動向 - ホスホイノシチド3-キナーゼ阻害剤のマーケットドライバー - ホスホイノシチド3-キナーゼ阻害剤の課題 - ホスホイノシチド3-キナーゼ阻害剤の阻害要因 ・主な調査結果

Market Analysis and Insights: Global Phosphoinositide 3-Kinase Inhibitor Market
The global Phosphoinositide 3-Kinase Inhibitor market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.
Fully considering the economic change by this health crisis, Pan-PI3K Inhibitors accounting for % of the Phosphoinositide 3-Kinase Inhibitor global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While CLL/SLL – Chronic Iymphocytic Ieukemia/Small Lymphocytic Lymphoma segment is altered to an % CAGR throughout this forecast period.
China Phosphoinositide 3-Kinase Inhibitor market size is valued at US$ million in 2021, while the North America and Europe Phosphoinositide 3-Kinase Inhibitor are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Phosphoinositide 3-Kinase Inhibitor landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Phosphoinositide 3-Kinase Inhibitor market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Phosphoinositide 3-Kinase Inhibitor market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Phosphoinositide 3-Kinase Inhibitor market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Phosphoinositide 3-Kinase Inhibitor market.
Global Phosphoinositide 3-Kinase Inhibitor Scope and Market Size
Phosphoinositide 3-Kinase Inhibitor market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Phosphoinositide 3-Kinase Inhibitor market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Pan-PI3K Inhibitors
Dual PI3K/mTOR inhibitors
Other
Segment by Application
CLL/SLL – Chronic Iymphocytic Ieukemia/Small Lymphocytic Lymphoma
FL – Follicular Iymphoma
Other Indications
By Company
Bayer AG
Gilead Sciences Inc.
Novartis AG
TG Therapeutics Inc.
Secura Bio, Inc.
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

レポート目次

---

1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Phosphoinositide 3-Kinase Inhibitor Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Pan-PI3K Inhibitors
1.2.3 Dual PI3K/mTOR inhibitors
1.2.4 Other
1.3 Market by Application
1.3.1 Global Phosphoinositide 3-Kinase Inhibitor Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 CLL/SLL – Chronic Iymphocytic Ieukemia/Small Lymphocytic Lymphoma
1.3.3 FL – Follicular Iymphoma
1.3.4 Other Indications
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Phosphoinositide 3-Kinase Inhibitor Market Perspective (2017-2028)
2.2 Phosphoinositide 3-Kinase Inhibitor Growth Trends by Region
2.2.1 Phosphoinositide 3-Kinase Inhibitor Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Phosphoinositide 3-Kinase Inhibitor Historic Market Size by Region (2017-2022)
2.2.3 Phosphoinositide 3-Kinase Inhibitor Forecasted Market Size by Region (2023-2028)
2.3 Phosphoinositide 3-Kinase Inhibitor Market Dynamics
2.3.1 Phosphoinositide 3-Kinase Inhibitor Industry Trends
2.3.2 Phosphoinositide 3-Kinase Inhibitor Market Drivers
2.3.3 Phosphoinositide 3-Kinase Inhibitor Market Challenges
2.3.4 Phosphoinositide 3-Kinase Inhibitor Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Phosphoinositide 3-Kinase Inhibitor Players by Revenue
3.1.1 Global Top Phosphoinositide 3-Kinase Inhibitor Players by Revenue (2017-2022)
3.1.2 Global Phosphoinositide 3-Kinase Inhibitor Revenue Market Share by Players (2017-2022)
3.2 Global Phosphoinositide 3-Kinase Inhibitor Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Phosphoinositide 3-Kinase Inhibitor Revenue
3.4 Global Phosphoinositide 3-Kinase Inhibitor Market Concentration Ratio
3.4.1 Global Phosphoinositide 3-Kinase Inhibitor Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Phosphoinositide 3-Kinase Inhibitor Revenue in 2021
3.5 Phosphoinositide 3-Kinase Inhibitor Key Players Head office and Area Served
3.6 Key Players Phosphoinositide 3-Kinase Inhibitor Product Solution and Service
3.7 Date of Enter into Phosphoinositide 3-Kinase Inhibitor Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Phosphoinositide 3-Kinase Inhibitor Breakdown Data by Type
4.1 Global Phosphoinositide 3-Kinase Inhibitor Historic Market Size by Type (2017-2022)
4.2 Global Phosphoinositide 3-Kinase Inhibitor Forecasted Market Size by Type (2023-2028)
5 Phosphoinositide 3-Kinase Inhibitor Breakdown Data by Application
5.1 Global Phosphoinositide 3-Kinase Inhibitor Historic Market Size by Application (2017-2022)
5.2 Global Phosphoinositide 3-Kinase Inhibitor Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Phosphoinositide 3-Kinase Inhibitor Market Size (2017-2028)
6.2 North America Phosphoinositide 3-Kinase Inhibitor Market Size by Type
6.2.1 North America Phosphoinositide 3-Kinase Inhibitor Market Size by Type (2017-2022)
6.2.2 North America Phosphoinositide 3-Kinase Inhibitor Market Size by Type (2023-2028)
6.2.3 North America Phosphoinositide 3-Kinase Inhibitor Market Share by Type (2017-2028)
6.3 North America Phosphoinositide 3-Kinase Inhibitor Market Size by Application
6.3.1 North America Phosphoinositide 3-Kinase Inhibitor Market Size by Application (2017-2022)
6.3.2 North America Phosphoinositide 3-Kinase Inhibitor Market Size by Application (2023-2028)
6.3.3 North America Phosphoinositide 3-Kinase Inhibitor Market Share by Application (2017-2028)
6.4 North America Phosphoinositide 3-Kinase Inhibitor Market Size by Country
6.4.1 North America Phosphoinositide 3-Kinase Inhibitor Market Size by Country (2017-2022)
6.4.2 North America Phosphoinositide 3-Kinase Inhibitor Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Phosphoinositide 3-Kinase Inhibitor Market Size (2017-2028)
7.2 Europe Phosphoinositide 3-Kinase Inhibitor Market Size by Type
7.2.1 Europe Phosphoinositide 3-Kinase Inhibitor Market Size by Type (2017-2022)
7.2.2 Europe Phosphoinositide 3-Kinase Inhibitor Market Size by Type (2023-2028)
7.2.3 Europe Phosphoinositide 3-Kinase Inhibitor Market Share by Type (2017-2028)
7.3 Europe Phosphoinositide 3-Kinase Inhibitor Market Size by Application
7.3.1 Europe Phosphoinositide 3-Kinase Inhibitor Market Size by Application (2017-2022)
7.3.2 Europe Phosphoinositide 3-Kinase Inhibitor Market Size by Application (2023-2028)
7.3.3 Europe Phosphoinositide 3-Kinase Inhibitor Market Share by Application (2017-2028)
7.4 Europe Phosphoinositide 3-Kinase Inhibitor Market Size by Country
7.4.1 Europe Phosphoinositide 3-Kinase Inhibitor Market Size by Country (2017-2022)
7.4.2 Europe Phosphoinositide 3-Kinase Inhibitor Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Phosphoinositide 3-Kinase Inhibitor Market Size (2017-2028)
8.2 Asia-Pacific Phosphoinositide 3-Kinase Inhibitor Market Size by Type
8.2.1 Asia-Pacific Phosphoinositide 3-Kinase Inhibitor Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Phosphoinositide 3-Kinase Inhibitor Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Phosphoinositide 3-Kinase Inhibitor Market Share by Type (2017-2028)
8.3 Asia-Pacific Phosphoinositide 3-Kinase Inhibitor Market Size by Application
8.3.1 Asia-Pacific Phosphoinositide 3-Kinase Inhibitor Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Phosphoinositide 3-Kinase Inhibitor Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Phosphoinositide 3-Kinase Inhibitor Market Share by Application (2017-2028)
8.4 Asia-Pacific Phosphoinositide 3-Kinase Inhibitor Market Size by Region
8.4.1 Asia-Pacific Phosphoinositide 3-Kinase Inhibitor Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Phosphoinositide 3-Kinase Inhibitor Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Phosphoinositide 3-Kinase Inhibitor Market Size (2017-2028)
9.2 Latin America Phosphoinositide 3-Kinase Inhibitor Market Size by Type
9.2.1 Latin America Phosphoinositide 3-Kinase Inhibitor Market Size by Type (2017-2022)
9.2.2 Latin America Phosphoinositide 3-Kinase Inhibitor Market Size by Type (2023-2028)
9.2.3 Latin America Phosphoinositide 3-Kinase Inhibitor Market Share by Type (2017-2028)
9.3 Latin America Phosphoinositide 3-Kinase Inhibitor Market Size by Application
9.3.1 Latin America Phosphoinositide 3-Kinase Inhibitor Market Size by Application (2017-2022)
9.3.2 Latin America Phosphoinositide 3-Kinase Inhibitor Market Size by Application (2023-2028)
9.3.3 Latin America Phosphoinositide 3-Kinase Inhibitor Market Share by Application (2017-2028)
9.4 Latin America Phosphoinositide 3-Kinase Inhibitor Market Size by Country
9.4.1 Latin America Phosphoinositide 3-Kinase Inhibitor Market Size by Country (2017-2022)
9.4.2 Latin America Phosphoinositide 3-Kinase Inhibitor Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Phosphoinositide 3-Kinase Inhibitor Market Size (2017-2028)
10.2 Middle East & Africa Phosphoinositide 3-Kinase Inhibitor Market Size by Type
10.2.1 Middle East & Africa Phosphoinositide 3-Kinase Inhibitor Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Phosphoinositide 3-Kinase Inhibitor Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Phosphoinositide 3-Kinase Inhibitor Market Share by Type (2017-2028)
10.3 Middle East & Africa Phosphoinositide 3-Kinase Inhibitor Market Size by Application
10.3.1 Middle East & Africa Phosphoinositide 3-Kinase Inhibitor Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Phosphoinositide 3-Kinase Inhibitor Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Phosphoinositide 3-Kinase Inhibitor Market Share by Application (2017-2028)
10.4 Middle East & Africa Phosphoinositide 3-Kinase Inhibitor Market Size by Country
10.4.1 Middle East & Africa Phosphoinositide 3-Kinase Inhibitor Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Phosphoinositide 3-Kinase Inhibitor Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Bayer AG
11.1.1 Bayer AG Company Details
11.1.2 Bayer AG Business Overview
11.1.3 Bayer AG Phosphoinositide 3-Kinase Inhibitor Introduction
11.1.4 Bayer AG Revenue in Phosphoinositide 3-Kinase Inhibitor Business (2017-2022)
11.1.5 Bayer AG Recent Developments
11.2 Gilead Sciences Inc.
11.2.1 Gilead Sciences Inc. Company Details
11.2.2 Gilead Sciences Inc. Business Overview
11.2.3 Gilead Sciences Inc. Phosphoinositide 3-Kinase Inhibitor Introduction
11.2.4 Gilead Sciences Inc. Revenue in Phosphoinositide 3-Kinase Inhibitor Business (2017-2022)
11.2.5 Gilead Sciences Inc. Recent Developments
11.3 Novartis AG
11.3.1 Novartis AG Company Details
11.3.2 Novartis AG Business Overview
11.3.3 Novartis AG Phosphoinositide 3-Kinase Inhibitor Introduction
11.3.4 Novartis AG Revenue in Phosphoinositide 3-Kinase Inhibitor Business (2017-2022)
11.3.5 Novartis AG Recent Developments
11.4 TG Therapeutics Inc.
11.4.1 TG Therapeutics Inc. Company Details
11.4.2 TG Therapeutics Inc. Business Overview
11.4.3 TG Therapeutics Inc. Phosphoinositide 3-Kinase Inhibitor Introduction
11.4.4 TG Therapeutics Inc. Revenue in Phosphoinositide 3-Kinase Inhibitor Business (2017-2022)
11.4.5 TG Therapeutics Inc. Recent Developments
11.5 Secura Bio, Inc.
11.5.1 Secura Bio, Inc. Company Details
11.5.2 Secura Bio, Inc. Business Overview
11.5.3 Secura Bio, Inc. Phosphoinositide 3-Kinase Inhibitor Introduction
11.5.4 Secura Bio, Inc. Revenue in Phosphoinositide 3-Kinase Inhibitor Business (2017-2022)
11.5.5 Secura Bio, Inc. Recent Developments
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer

List of Tables
Table 1. Global Phosphoinositide 3-Kinase Inhibitor Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Pan-PI3K Inhibitors
Table 3. Key Players of Dual PI3K/mTOR inhibitors
Table 4. Key Players of Other
Table 5. Global Phosphoinositide 3-Kinase Inhibitor Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 6. Global Phosphoinositide 3-Kinase Inhibitor Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 7. Global Phosphoinositide 3-Kinase Inhibitor Market Size by Region (2017-2022) & (US$ Million)
Table 8. Global Phosphoinositide 3-Kinase Inhibitor Market Share by Region (2017-2022)
Table 9. Global Phosphoinositide 3-Kinase Inhibitor Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 10. Global Phosphoinositide 3-Kinase Inhibitor Market Share by Region (2023-2028)
Table 11. Phosphoinositide 3-Kinase Inhibitor Market Trends
Table 12. Phosphoinositide 3-Kinase Inhibitor Market Drivers
Table 13. Phosphoinositide 3-Kinase Inhibitor Market Challenges
Table 14. Phosphoinositide 3-Kinase Inhibitor Market Restraints
Table 15. Global Phosphoinositide 3-Kinase Inhibitor Revenue by Players (2017-2022) & (US$ Million)
Table 16. Global Phosphoinositide 3-Kinase Inhibitor Revenue Share by Players (2017-2022)
Table 17. Global Top Phosphoinositide 3-Kinase Inhibitor by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Phosphoinositide 3-Kinase Inhibitor as of 2021)
Table 18. Ranking of Global Top Phosphoinositide 3-Kinase Inhibitor Companies by Revenue (US$ Million) in 2021
Table 19. Global 5 Largest Players Market Share by Phosphoinositide 3-Kinase Inhibitor Revenue (CR5 and HHI) & (2017-2022)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Phosphoinositide 3-Kinase Inhibitor Product Solution and Service
Table 22. Date of Enter into Phosphoinositide 3-Kinase Inhibitor Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Phosphoinositide 3-Kinase Inhibitor Market Size by Type (2017-2022) & (US$ Million)
Table 25. Global Phosphoinositide 3-Kinase Inhibitor Revenue Market Share by Type (2017-2022)
Table 26. Global Phosphoinositide 3-Kinase Inhibitor Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 27. Global Phosphoinositide 3-Kinase Inhibitor Revenue Market Share by Type (2023-2028)
Table 28. Global Phosphoinositide 3-Kinase Inhibitor Market Size by Application (2017-2022) & (US$ Million)
Table 29. Global Phosphoinositide 3-Kinase Inhibitor Revenue Share by Application (2017-2022)
Table 30. Global Phosphoinositide 3-Kinase Inhibitor Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 31. Global Phosphoinositide 3-Kinase Inhibitor Revenue Share by Application (2023-2028)
Table 32. North America Phosphoinositide 3-Kinase Inhibitor Market Size by Type (2017-2022) & (US$ Million)
Table 33. North America Phosphoinositide 3-Kinase Inhibitor Market Size by Type (2023-2028) & (US$ Million)
Table 34. North America Phosphoinositide 3-Kinase Inhibitor Market Size by Application (2017-2022) & (US$ Million)
Table 35. North America Phosphoinositide 3-Kinase Inhibitor Market Size by Application (2023-2028) & (US$ Million)
Table 36. North America Phosphoinositide 3-Kinase Inhibitor Market Size by Country (2017-2022) & (US$ Million)
Table 37. North America Phosphoinositide 3-Kinase Inhibitor Market Size by Country (2023-2028) & (US$ Million)
Table 38. Europe Phosphoinositide 3-Kinase Inhibitor Market Size by Type (2017-2022) & (US$ Million)
Table 39. Europe Phosphoinositide 3-Kinase Inhibitor Market Size by Type (2023-2028) & (US$ Million)
Table 40. Europe Phosphoinositide 3-Kinase Inhibitor Market Size by Application (2017-2022) & (US$ Million)
Table 41. Europe Phosphoinositide 3-Kinase Inhibitor Market Size by Application (2023-2028) & (US$ Million)
Table 42. Europe Phosphoinositide 3-Kinase Inhibitor Market Size by Country (2017-2022) & (US$ Million)
Table 43. Europe Phosphoinositide 3-Kinase Inhibitor Market Size by Country (2023-2028) & (US$ Million)
Table 44. Asia Pacific Phosphoinositide 3-Kinase Inhibitor Market Size by Type (2017-2022) & (US$ Million)
Table 45. Asia Pacific Phosphoinositide 3-Kinase Inhibitor Market Size by Type (2023-2028) & (US$ Million)
Table 46. Asia Pacific Phosphoinositide 3-Kinase Inhibitor Market Size by Application (2017-2022) & (US$ Million)
Table 47. Asia Pacific Phosphoinositide 3-Kinase Inhibitor Market Size by Application (2023-2028) & (US$ Million)
Table 48. Asia Pacific Phosphoinositide 3-Kinase Inhibitor Market Size by Region (2017-2022) & (US$ Million)
Table 49. Asia Pacific Phosphoinositide 3-Kinase Inhibitor Market Size by Region (2023-2028) & (US$ Million)
Table 50. Latin America Phosphoinositide 3-Kinase Inhibitor Market Size by Type (2017-2022) & (US$ Million)
Table 51. Latin America Phosphoinositide 3-Kinase Inhibitor Market Size by Type (2023-2028) & (US$ Million)
Table 52. Latin America Phosphoinositide 3-Kinase Inhibitor Market Size by Application (2017-2022) & (US$ Million)
Table 53. Latin America Phosphoinositide 3-Kinase Inhibitor Market Size by Application (2023-2028) & (US$ Million)
Table 54. Latin America Phosphoinositide 3-Kinase Inhibitor Market Size by Country (2017-2022) & (US$ Million)
Table 55. Latin America Phosphoinositide 3-Kinase Inhibitor Market Size by Country (2023-2028) & (US$ Million)
Table 56. Middle East and Africa Phosphoinositide 3-Kinase Inhibitor Market Size by Type (2017-2022) & (US$ Million)
Table 57. Middle East and Africa Phosphoinositide 3-Kinase Inhibitor Market Size by Type (2023-2028) & (US$ Million)
Table 58. Middle East and Africa Phosphoinositide 3-Kinase Inhibitor Market Size by Application (2017-2022) & (US$ Million)
Table 59. Middle East and Africa Phosphoinositide 3-Kinase Inhibitor Market Size by Application (2023-2028) & (US$ Million)
Table 60. Middle East and Africa Phosphoinositide 3-Kinase Inhibitor Market Size by Country (2017-2022) & (US$ Million)
Table 61. Middle East and Africa Phosphoinositide 3-Kinase Inhibitor Market Size by Country (2023-2028) & (US$ Million)
Table 62. Bayer AG Company Details
Table 63. Bayer AG Business Overview
Table 64. Bayer AG Phosphoinositide 3-Kinase Inhibitor Product
Table 65. Bayer AG Revenue in Phosphoinositide 3-Kinase Inhibitor Business (2017-2022) & (US$ Million)
Table 66. Bayer AG Recent Developments
Table 67. Gilead Sciences Inc. Company Details
Table 68. Gilead Sciences Inc. Business Overview
Table 69. Gilead Sciences Inc. Phosphoinositide 3-Kinase Inhibitor Product
Table 70. Gilead Sciences Inc. Revenue in Phosphoinositide 3-Kinase Inhibitor Business (2017-2022) & (US$ Million)
Table 71. Gilead Sciences Inc. Recent Developments
Table 72. Novartis AG Company Details
Table 73. Novartis AG Business Overview
Table 74. Novartis AG Phosphoinositide 3-Kinase Inhibitor Product
Table 75. Novartis AG Revenue in Phosphoinositide 3-Kinase Inhibitor Business (2017-2022) & (US$ Million)
Table 76. Novartis AG Recent Developments
Table 77. TG Therapeutics Inc. Company Details
Table 78. TG Therapeutics Inc. Business Overview
Table 79. TG Therapeutics Inc. Phosphoinositide 3-Kinase Inhibitor Product
Table 80. TG Therapeutics Inc. Revenue in Phosphoinositide 3-Kinase Inhibitor Business (2017-2022) & (US$ Million)
Table 81. TG Therapeutics Inc. Recent Developments
Table 82. Secura Bio, Inc. Company Details
Table 83. Secura Bio, Inc. Business Overview
Table 84. Secura Bio, Inc. Phosphoinositide 3-Kinase Inhibitor Product
Table 85. Secura Bio, Inc. Revenue in Phosphoinositide 3-Kinase Inhibitor Business (2017-2022) & (US$ Million)
Table 86. Secura Bio, Inc. Recent Developments
Table 87. Research Programs/Design for This Report
Table 88. Key Data Information from Secondary Sources
Table 89. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Phosphoinositide 3-Kinase Inhibitor Market Share by Type: 2021 VS 2028
Figure 2. Pan-PI3K Inhibitors Features
Figure 3. Dual PI3K/mTOR inhibitors Features
Figure 4. Other Features
Figure 5. Global Phosphoinositide 3-Kinase Inhibitor Market Share by Application: 2021 VS 2028
Figure 6. CLL/SLL - Chronic Iymphocytic Ieukemia/Small Lymphocytic Lymphoma Case Studies
Figure 7. FL - Follicular Iymphoma Case Studies
Figure 8. Other Indications Case Studies
Figure 9. Phosphoinositide 3-Kinase Inhibitor Report Years Considered
Figure 10. Global Phosphoinositide 3-Kinase Inhibitor Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 11. Global Phosphoinositide 3-Kinase Inhibitor Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 12. Global Phosphoinositide 3-Kinase Inhibitor Market Share by Region: 2021 VS 2028
Figure 13. Global Phosphoinositide 3-Kinase Inhibitor Market Share by Players in 2021
Figure 14. Global Top Phosphoinositide 3-Kinase Inhibitor Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Phosphoinositide 3-Kinase Inhibitor as of 2021)
Figure 15. The Top 10 and 5 Players Market Share by Phosphoinositide 3-Kinase Inhibitor Revenue in 2021
Figure 16. North America Phosphoinositide 3-Kinase Inhibitor Market Size YoY (2017-2028) & (US$ Million)
Figure 17. North America Phosphoinositide 3-Kinase Inhibitor Market Size Market Share by Type (2017-2028)
Figure 18. North America Phosphoinositide 3-Kinase Inhibitor Market Size Market Share by Application (2017-2028)
Figure 19. North America Phosphoinositide 3-Kinase Inhibitor Market Size Share by Country (2017-2028)
Figure 20. United States Phosphoinositide 3-Kinase Inhibitor Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 21. Canada Phosphoinositide 3-Kinase Inhibitor Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. Europe Phosphoinositide 3-Kinase Inhibitor Market Size YoY (2017-2028) & (US$ Million)
Figure 23. Europe Phosphoinositide 3-Kinase Inhibitor Market Size Market Share by Type (2017-2028)
Figure 24. Europe Phosphoinositide 3-Kinase Inhibitor Market Size Market Share by Application (2017-2028)
Figure 25. Europe Phosphoinositide 3-Kinase Inhibitor Market Size Share by Country (2017-2028)
Figure 26. Germany Phosphoinositide 3-Kinase Inhibitor Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. France Phosphoinositide 3-Kinase Inhibitor Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. U.K. Phosphoinositide 3-Kinase Inhibitor Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Italy Phosphoinositide 3-Kinase Inhibitor Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Russia Phosphoinositide 3-Kinase Inhibitor Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Nordic Countries Phosphoinositide 3-Kinase Inhibitor Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Asia-Pacific Phosphoinositide 3-Kinase Inhibitor Market Size YoY (2017-2028) & (US$ Million)
Figure 33. Asia Pacific Phosphoinositide 3-Kinase Inhibitor Market Size Market Share by Type (2017-2028)
Figure 34. Asia Pacific Phosphoinositide 3-Kinase Inhibitor Market Size Market Share by Application (2017-2028)
Figure 35. Asia Pacific Phosphoinositide 3-Kinase Inhibitor Market Size Share by Region (2017-2028)
Figure 36. China Phosphoinositide 3-Kinase Inhibitor Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. Japan Phosphoinositide 3-Kinase Inhibitor Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. South Korea Phosphoinositide 3-Kinase Inhibitor Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Southeast Asia Phosphoinositide 3-Kinase Inhibitor Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. India Phosphoinositide 3-Kinase Inhibitor Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Australia Phosphoinositide 3-Kinase Inhibitor Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
Figure 42. Latin America Phosphoinositide 3-Kinase Inhibitor Market Size YoY (2017-2028) & (US$ Million)
Figure 43. Latin America Phosphoinositide 3-Kinase Inhibitor Market Size Market Share by Type (2017-2028)
Figure 44. Latin America Phosphoinositide 3-Kinase Inhibitor Market Size Market Share by Application (2017-2028)
Figure 45. Latin America Phosphoinositide 3-Kinase Inhibitor Market Size Share by Country (2017-2028)
Figure 46. Mexico Phosphoinositide 3-Kinase Inhibitor Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 47. Brazil Phosphoinositide 3-Kinase Inhibitor Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 48. Middle East & Africa Phosphoinositide 3-Kinase Inhibitor Market Size YoY (2017-2028) & (US$ Million)
Figure 49. Middle East and Africa Phosphoinositide 3-Kinase Inhibitor Market Size Market Share by Type (2017-2028)
Figure 50. Middle East and Africa Phosphoinositide 3-Kinase Inhibitor Market Size Market Share by Application (2017-2028)
Figure 51. Middle East and Africa Phosphoinositide 3-Kinase Inhibitor Market Size Share by Country (2017-2028)
Figure 52. Turkey Phosphoinositide 3-Kinase Inhibitor Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 53. Saudi Arabia Phosphoinositide 3-Kinase Inhibitor Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 54. UAE Phosphoinositide 3-Kinase Inhibitor Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 55. Bayer AG Revenue Growth Rate in Phosphoinositide 3-Kinase Inhibitor Business (2017-2022)
Figure 56. Gilead Sciences Inc. Revenue Growth Rate in Phosphoinositide 3-Kinase Inhibitor Business (2017-2022)
Figure 57. Novartis AG Revenue Growth Rate in Phosphoinositide 3-Kinase Inhibitor Business (2017-2022)
Figure 58. TG Therapeutics Inc. Revenue Growth Rate in Phosphoinositide 3-Kinase Inhibitor Business (2017-2022)
Figure 59. Secura Bio, Inc. Revenue Growth Rate in Phosphoinositide 3-Kinase Inhibitor Business (2017-2022)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed

---